Insys Therapeutics names independent director
Insight Weekly: Loan delinquencies up; US money supply falls; coal employment grows
Insight Weekly: Loan-to-deposit ratio rises; inventory turnovers ebb; miners add female leaders
Debt Ceiling Debate: IR Teams Should Prepare for Potential Market Downturns
Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up
Chandler, Ariz.-based Insys Therapeutics Inc. appointed Elizabeth Bohlen as an independent board member.
Bohlen currently serves as the COO of the Archdiocese of Chicago, where she oversees the organization's administrative functions.
Insys Therapeutics is a specialty pharmaceutical company that develops and commercializes drugs and drug delivery systems.
